Optimal timing of prehospital advanced airway management and epinephrine administration for out-of-hospital cardiac arrest
Optimal timing of prehospital advanced airway management and epinephrine administration for out-of-hospital cardiac arrest
批准号:
10580352
负责人:
Masashi Okubo
金额:
$11.93万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-12-15 至 2024-11-30
关键词:
AddressAdultAffectAmericanAmerican Heart AssociationApplications GrantsCanadaCardiopulmonary ResuscitationCaringChildhoodClinicalConsensusDataEmergency medical serviceEpinephrineEventFutureGoalsGrantGuidelinesHospitalsIndividualInternationalInterventionIntratracheal IntubationKnowledgeLifeLinkMasksMedicalMethodologyModelingOutcomePatient-Focused OutcomesPatientsPlayPopulationPre-hospitalization carePrincipal InvestigatorProbabilityPublic HealthRecommendationRegistriesResearchResuscitationRiskRoleScienceSurvival AnalysisSystemTechniquesTimeTime ManagementUnited Statescardiovascular emergencycare systemscohortfunctional disabilityfunctional outcomesfunctional statusimproved outcomemedication administrationmortalityout-of-hospital cardiac arrestpediatric patientssecondary analysisstomach cardiasurvival outcomesystematic reviewtime useventilation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
The overarching goal of this R21 Grant proposal is to identify the optimal timing of prehospital advance life
support (ALS) interventions for patients with out-of-hospital cardiac arrest (OHCA). The ALS interventions
include advanced airway management (AAM: i.e., endotracheal intubation and supraglottic airway placement)
and epinephrine administration. OHCA is a major public health problem worldwide, annually affecting over
356,000 Americans with substantially high rates of mortality and functional disability. Emergency medical
services (EMS) play an important role for patients with OHCA by providing initial prehospital care, including the
ALS interventions in the field. However, the optimal timing of the ALS interventions remains unclear. The 2019
International Liaison Committee on Resuscitation (ILCOR) Summary Statement, International Consensus on
Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment
Recommendations identified the optimal time of both AAM and epinephrine administration as key knowledge
gaps. We recently found that, for adults with both shockable and nonshockable rhythms, benefit of epinephrine
decreased as the administration was delayed, using the Resuscitation Outcomes Consortium (ROC) registry, a
large multicenter OHCA registry in the United States and Canada. This R21 Grant project proposes to further
expand our research into AAM and pediatric population, analyzing the ROC data. Specific research Aims
include identifying the optimal timing of AAM (Aim 1A) and endotracheal intubation (Aim 1B) for adult patients
with OHCA, the optimal timing of AAM (Aim 2A) and endotracheal intubation (Aim 2B) for pediatric patients
with OHCA, and the optimal timing of epinephrine (Aim3) for pediatric patients with OHCA. This R21 Grant
application will provide the Principal Investigator (PI) with protected time to achieve research aims to improve
outcomes for patients with OHCA. The results of this R21 proposal will provide crucial information on the timing
of ALS interventions for OHCA and inform future national and international resuscitation guidelines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金